Reading this on a mobile device? Try our optimized mobile version here:

April 26, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Oncologists call for reduction in drug prices
    A report in the journal Blood finds 11 of 12 cancer drugs approved by the FDA last year cost more than $100,000 annually, making it difficult for patients to obtain treatment for conditions such as chronic myeloid leukemia. It's part of a broader trend of high-cost treatments, researchers noted, reporting that the mean monthly cost of cancer drugs overall has increased from $5,000 to more than $10,000 in the past decade. More than 100 of the world's leading cancer specialists urged drug companies to address the issue, arguing that the prices are unsustainable. "Advocating for lower drug prices is a necessity to save the lives of patients," they wrote. The New York Times (tiered subscription model) (4/25), U.S. News & World Report/HealthDay News (4/25) LinkedInFacebookTwitterEmail this Story
Time to try a new anti-Fyb?
If you are tired of your sub-par reactions, Quotient has a newly approved anti-Fyb, as well as hard-to-find Anti-s, Anti-Wra and other rare antisera that are worth a try. Since Quotient is only focused on manual testing, our goal is to bring you products specific to your unique testing needs. See what we have to offer.

  Science & Health 
  • Portable tool IDs Candida infection in blood samples
    A study in Science Translational Medicine found that a portable, magnetic resonance-based diagnostic tool can identify fungal bloodstream infections involving five Candida species in less than three hours. Researchers documented 98% positive agreement and 100% negative agreement between the device and diagnoses based on blood cultures. "This study shows that the nanoparticle- and T2MR-based detection method is rapid and amenable to automation and offers clinicians the opportunity to detect and identify multiple human pathogens within hours of sample collection," researchers wrote. News (4/25) LinkedInFacebookTwitterEmail this Story
  • Live poultry confirmed to be at least one source of H7N9
    A recently completed study of H7N9, the newly identified avian influenza virus that has infected 109 people in China, found it is directly transmitted from live poultry to humans. "The evidence ... suggests it is a pure poultry-to-human transmission and that controlling [infections in people] will therefore depend on controlling the epidemic in poultry," said study leader Kwok-Yung Yuen of the University of Hong Kong. The study identifies poultry as only one source because, according to the World Health Organization, 40% of infected people had no apparent contact with poultry. Reuters (4/25) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • More Americans are open to donating a kidney to a stranger
    A national survey by the Mayo Clinic found that almost 50% of people say they would consider giving a kidney to a stranger, up from 24% in 2001. Eighty-four percent of respondents said they would consider donating a kidney or a part of their liver to a close friend or relative. HealthDay News (4/25) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Stemedica licenses stem cells to Kalbe Farma
    Stem Cell and Cancer Institute, a unit of PT Kalbe Farma, secured exclusive licensing rights to Stemedica Asia's ischemic-tolerant adult allogeneic mesenchymal and neural stem cells for use in clinical research in the Philippines, Thailand and Indonesia. The deal could be extended to additional countries in Asia. Genetic Engineering & Biotechnology News (4/25) LinkedInFacebookTwitterEmail this Story
  • Accountable care helps hospitals improve quality, lower costs
    Accountable care, which provides financial incentives for health care providers to lower care costs and improve quality, is slowly gaining ground under the Affordable Care Act, with about 4 million Medicare enrollees covered by 428 accountable care organizations nationwide. Advocate Health Care, a pioneer in accountable care in Oak Brook, Ill., has decreased the number of hospital admissions by 6% and lowered the average length of stay using coordinated care, quality control measures and performance report cards. The New York Times (tiered subscription model) (4/23) LinkedInFacebookTwitterEmail this Story
  • Survey sheds light on MU barriers, top HIT trends for 2013
    Respondents to a Stoltenberg Consulting survey cited confusion over the meaningful use rules as the biggest obstacle to achieving MU, followed by competing health IT efforts and lack of IT workers, funding and other resources. The survey also notes that health information exchange will be the biggest HIT trend this year, followed by mobile health and clinical analytics. Healthcare IT News (4/23) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA partners with Corning on detector for bogus malaria drugs
    Corning will manufacture a handheld, battery-operated device developed by the FDA to detect fake or substandard malaria drugs. The device will be tested first in Ghana, then in other areas where malaria rates are high and counterfeit drugs are common. The FDA plans to distribute the device in coordination with the NIH, CDC, USAID and other organizations. Reuters (4/24), The Wall Street Journal (4/24) LinkedInFacebookTwitterEmail this Story
  • HHS committee approves guidance for Internet-based research
    An HHS advisory committee endorsed a set of 20 ethics recommendations to guide researchers relying on the Internet. For example, researchers conducting an online survey could rely on respondents to check a box confirming they have not misrepresented themselves, but for studies with more personal impact, such as a clinical trial, participants would have to prove their identities, age and understanding of the trial. Critics say the guidelines might subject more areas of research to scrutiny by institutional review boards, but supporters say it might allow those boards to be less guarded. Nature (free content) (4/24) LinkedInFacebookTwitterEmail this Story
  Association News 
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Manager, Collections DepartmentBlood Centers of the PacificUS - CA - Millbrae
Sr Medical Director - CorporateBlood Systems, Inc.US - AZ - Scottsdale
Information Systems Quality & Audit SpecialistBlood Systems, Inc.US - AZ - Scottsdale
Chief Executive OfficerAmerica's Blood CentersUS - DC - Washington
Science and Medical WriterAABBUS - MD - Bethesda
Consultant - Cellular TherapyAABBUS - MD - Bethesda
Consultant, Blood Banking and Cellular TherapiesAABBUS - MD - Bethesda
Click here to view more job listings.

I wish to suggest that a man may be very industrious, and yet not spend his time well. There is no more fatal blunderer than he who consumes the greater part of life getting his living."
--Henry David Thoreau,
American author and poet

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information